Abstract
The first aim of the study was to identify when deliberate self-harm (DSH) behavior ceased in patients with borderline symptoms undergoing dialectical behavioral treatment (DBT). The second aim was to compare patients who ceased their self-harm behavior early or late in the course of treatment, with regard to demographics, comorbidity, and symptom severity. The study used a naturalistic design and included 75 treatment completers at an outpatient DBT clinic. Of these 75 patients, 46 presented with self-harming behavior at pre-treatment. These 46 participants where split into two groups, based on median amount of time before ceasing self-harm behavior, termed early (up to 8 weeks) and late (8+ weeks) responders. Treatment duration varied from 16 to 160 weeks. Patients were assessed pre- and post-treatment using measures of depression, hopelessness, personality traits, quality of life, and global assessment of symptoms and functioning. The majority (93.5%) ceased their self-harming within the first year, and the average number of weeks was 15.5 (SD = 17.8). Twenty-five percent of patients ceased their DSH behavior during the first week of treatment. For the remaining patients, the cessation of DSH continued gradually across a 1 year period. We found no differences between early and late responders with respect to demographics, comorbidity, symptom severity, or treatment outcome. None of the patients committed suicide. The findings indicate that self-harming behavior decreases gradually across the first year after starting DBT.
Highlights
Deliberate self-harm behavior (DSH) is a transdiagnostic phenomenon, occurring across a range of psychiatric disorders (Selby et al, 2012)
One of the psychiatric diagnoses strongly associated with deliberate self-harm is borderline personality disorder (BPD), were the presence of DSH is one of the diagnostic criteria for the disorder (Selby et al, 2012)
We found no significant difference between early and late responders on demographic variables
Summary
Deliberate self-harm behavior (DSH) is a transdiagnostic phenomenon, occurring across a range of psychiatric disorders (Selby et al, 2012). The presence of DSH in BPD complicates the clinical assessment of suicidality, and may lead to inexpedient psychiatric hospitalizations and therapist burn-out which, at worst, could deteriorate long-term treatment prognosis (Mehlum and Jensen, 2006; van den Bosch et al, 2014). This necessitates the implementation of effective treatment that improves patients’ self-harming behavior
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.